Donald Trump shocked everyone on Hydroxychloroquine medicine. He talked about the research that took place in American related to medicine.
Then, the US President took the u-turn on Hydroxychloroquine usage. It is shocking news for the world battling with the coronavirus disease.
The scientist’s team of the University of South Carolina analyzed on the medicines for the COVID19 treatment.
They took the samples of hydroxychloroquine and azithromycin for the testing procedure. Then, they prepared a well-researched report on it—the combination of the hydroxychloroquine and azithromycin given to the patients affected with the virus.
However, the study raised the concerns of the medical professionals on the coronavirus treatment procedures. All the Veterans Health Administration medical centers of the USA and the South Carolina University research team prepared the material on the medicine.
They looked concerned about the clinical outcomes on the dosages of the two medicines. Based on the findings, the scientist’s team cannot find any evidence that hydroxychloroquine can cure the coronavirus.
Trump shared the South Carolina University study on hydroxychloroquine medicine.
They accessed the data of the COVID19 positive patients admitted in the hospitals on April 11. Meanwhile, the team divided the patients into three groups.
All the patients in the groups had given the prescribed combination of medicines. On the other hand, if hydroxychloroquine medicine given alone increases the death risk.
In the coming months, they are using the best possible outcomes of the illness—some limitations mentioned by the scientists’ group.
They involved the median age of men is 65 years old. In addition to this, it does not include the positive coronavirus cases of women and young children.
Trump shared the reported news in the media. He revealed the study conducted by the medical organizations and the South Carolina University of USA.
In the past, India gave hydroxychloroquine to the USA. The President of American thanked him for the support too.